Standout Papers

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-de... 2003 2026 2010 2018 628
  1. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies (2003)
    Jean‐Pierre J. Issa, Guillermo Garcia‐Manero et al. Blood

Immediate Impact

2 by Nobel laureates 20 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

A signal processing and deep learning framework for methylation detection using Oxford Nanopore sequencing
2024 Standout
Transient loss of Polycomb components induces an epigenetic cancer fate
2024 StandoutNature
6 intermediate papers

Works of Emel Bayar being referenced

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
2003 Standout

Author Peers

Author Last Decade Papers Cites
Emel Bayar 144 307 608 8 790
Brigit R. Taylor 58 271 528 13 885
Jan Davis 223 606 429 7 800
Barbara Adler‐Brecher 112 193 458 9 665
Linda Holmfeldt 273 272 384 14 723
S. Jani-Sait 75 188 402 12 658
Karin B. Gale 277 313 376 8 756
T Yamagami 273 263 708 15 903
G. F. Barker 344 507 529 7 888
Annette Orleth 84 399 612 13 827
Frank J. Godinho 103 291 428 12 836

All Works

Loading papers...

Rankless by CCL
2026